clinical trial · NCT06692647
A Clinical Study of MK-4318 and Diltiazem in Healthy People (MK-4318-003)
Merck Sharp & Dohme LLC·phase1·completed·n = 19
HealthyPainMK-4318Diltiazem
brief summary
The goal of this study is to learn what happens to MK-4318 in a person's body over time. Researchers will compare what happens to levels of MK-4318 in people's blood when it is taken with and without diltiazem. Researchers also want to learn about the safety of MK-4318 taken with and without diltiazem and if people tolerate them.
started
Feb 9, 2024
primary completion
Apr 11, 2024
completion
Apr 11, 2024
last updated
Nov 18, 2024
official title
A Two-period Study to Evaluate the Effects of Multiple Oral Doses of Diltiazem on the Single-dose Pharmacokinetics of MK-4318 in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol